Status:

COMPLETED

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Lead Sponsor:

Alliance for Clinical Trials in Oncology

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Breast Cancer

Eligibility:

FEMALE

45+ years

Brief Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer....

Detailed Description

OBJECTIVES: Primary * To identify genetic variation, as measured by single nucleotide polymorphisms, that is associated with musculoskeletal adverse events in specimens from postmenopausal women wit...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically or cytologically confirmed invasive breast cancer
  • Complete resection of primary tumor
  • Stage I-III (T1-3, N0-3, M0) disease
  • Enrolled in clinical trial CAN-NCIC-MA27.
  • No locally recurrent or metastatic breast cancer
  • Hormone receptor status:
  • Estrogen receptor- or progesterone receptor-positive disease
  • PATIENT CHARACTERISTICS:
  • Postmenopausal status, defined as one of the following:
  • At least 60 years old
  • Age 45-59 years with spontaneous cessation of menses for \> 12 months prior to chemotherapy or study randomization
  • Age 45-59 years with cessation of menses for \< 12 months or secondary to hysterectomy AND a follicle-stimulating hormone (FSH) level in the postmenopausal range (or \> 34.4 IU/L)
  • Age 45-59 years on hormone replacement therapy (HRT) and discontinued HRT at diagnosis of breast cancer AND FSH level in the postmenopausal range (or \> 34.4 IU/L)
  • Bilateral oophorectomy
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

Exclusion

    Key Trial Info

    Start Date :

    September 1 2008

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2018

    Estimated Enrollment :

    364 Patients enrolled

    Trial Details

    Trial ID

    NCT00968214

    Start Date

    September 1 2008

    End Date

    September 1 2018

    Last Update

    February 21 2020

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.